SMi Group reports: The 22nd Pain Therapeutics Conference welcomes The Pain Society and Eptiva Therapeutics to deliver keynote opening addresses Taking place on 4th to 5th May 2022 in London UK, SMi’s 22nd Annual Pain […]
Glenmark Pharmaceuticals and Canada-based SaNOtize Research & Development have introduced the Nitric Oxide Nasal Spray (NONS) to treat Covid-19 in adult patients in India. To be marketed under the brand name FabiSpray, the treatment is […]
China’s National Medical Products Administration (NMPA) has granted approval to GlaxoSmithKline’s (GSK) Benlysta (belimumab) to treat active lupus nephritis (LN) in adults. The treatment is intended for LN patients who are currently receiving standard of […]
Ventus Therapeutics has raised $140m in a Series C funding round co-led by SoftBank Vision Fund 2 and RA Capital Management to accelerate its drug discovery platform, ReSOLVE. The financing round saw participation from Qatar […]
Collegium Pharmaceutical has signed a definitive merger agreement for the acquisition of all outstanding shares of BioDelivery Sciences International (BDSI) in an all-cash deal for $5.60 each share or a total equity value of nearly […]